XETRA - Delayed Quote EUR

Bio-Gate AG (BIG1.DE)

Compare
0.7900 +0.0050 (+0.64%)
At close: December 30 at 2:06:10 PM GMT+1
Loading Chart for BIG1.DE
DELL
  • Previous Close 0.7850
  • Open 0.7900
  • Bid 0.7400 x --
  • Ask 0.8400 x --
  • Day's Range 0.7900 - 0.7900
  • 52 Week Range 0.5600 - 1.6500
  • Volume 375
  • Avg. Volume 4,580
  • Market Cap (intraday) 7.303M
  • Beta (5Y Monthly) 0.19
  • PE Ratio (TTM) --
  • EPS (TTM) -0.2200
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Bio-Gate AG provides technologies and customized solutions for health and hygiene in Germany. The company offers HyProtect, a plasma coating, which protects the surfaces of medical implants against bacterial colonization. It also provides MicroSilver BG elemental microporous silver additives. The company's products are used in large and medium-sized medical technology companies, pharmaceutical distributors, distribution companies, industrial companies, public sector companies, and hygiene-sensitive institutions. The company was incorporated in 2005 and is based in Nuremberg, Germany.

www.bio-gate.de

45

Full Time Employees

December 31

Fiscal Year Ends

Recent News: BIG1.DE

View More

Performance Overview: BIG1.DE

Trailing total returns as of 12/30/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

BIG1.DE
28.83%
DAX P
18.85%

1-Year Return

BIG1.DE
28.83%
DAX P
18.85%

3-Year Return

BIG1.DE
79.74%
DAX P
25.59%

5-Year Return

BIG1.DE
43.57%
DAX P
49.28%

Compare To: BIG1.DE

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: BIG1.DE

View More

Valuation Measures

As of 12/30/2024
  • Market Cap

    6.84M

  • Enterprise Value

    6.36M

  • Trailing P/E

    --

  • Forward P/E

    7.85

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.96

  • Price/Book (mrq)

    3.17

  • Enterprise Value/Revenue

    0.84

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -26.32%

  • Return on Assets (ttm)

    -25.82%

  • Return on Equity (ttm)

    -68.91%

  • Revenue (ttm)

    7.61M

  • Net Income Avi to Common (ttm)

    -2M

  • Diluted EPS (ttm)

    -0.2200

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    476k

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    -169.26k

Research Analysis: BIG1.DE

View More

People Also Watch